869627-85-0

Basic information

• Product Name: 3(R,S)-Hydroxy Desogestrel
• Synonyms: (17a)-13-Ethyl-11-methylene-18,19-dinorpregn-4-en-20-yne-3,17-dio;3(R,S)-Hydroxy Desogestrel;(17a)-13-Ethyl-11-methylene-18,19-dinorpregn-4-en-20-yne-3,17-diol;(17α)-13-Ethyl-11-Methylene-18,19-dinorpregn-4-en-20-yne-3,17-diol
• CAS NO: 869627-85-0
• Molecular Formula: C22H30O2
• Molecular Weight: 326.477
• Product Categories: Various Metabolites and Impurities;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals;Steroids
• Mol File: 869627-85-0.mol

Chemical Properties

• Boiling Point: 470.449°C at 760 mmHg
• Flash Point: 210.624°C
• Appearance: /
• Density: 1.139g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.582
• Storage Temp.: -20°C Freezer, Under inert atmosphere
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• CAS DataBase Reference: 3(R,S)-Hydroxy Desogestrel(CAS DataBase Reference)
• NIST Chemistry Reference: 3(R,S)-Hydroxy Desogestrel(869627-85-0)
• EPA Substance Registry System: 3(R,S)-Hydroxy Desogestrel(869627-85-0)

Safety Data

• Hazardous Substances Data: 869627-85-0(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 869627-85-0 differently. You can refer to the following data:
1. A metabolite of Desogestrel
2. A metabolite of Desogestrel.

InChI:InChI=1/C22H30O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,16-20,23-24H,3-4,6-11,13H2,1H3/t16?,17-,18-,19?,20?,21-,22?/m0/s1

Upstream product

• 54048-10-1 etonogestrel 

Relevant articles and documents

Preparation of 3-ketodesogestrel metabolites by microbial transformation and chemical synthesis

Specific microbial reactions were used for the preparation of metabolites of 3-ketodesogestrel (13-ethyl-17β-hydroxy-11-methylene-18,19- dinor-17α-pregn-4-en-20-yn-3-one, the active of the progestagen desogestrel. Clostridium paraputrificum transformed 3-ketodesogestrel (KDG) to the 5β- dihydro and tetrahydro metabolites 13-ethyl-17β-hydroxy-11-methylene-18,19- dinor-5β,17α-pregnan-20-yn-3-one and 13-ethyl-11-methylene-18,19-dinor- 5β,17α-pregnan-20-yne-3α,17β-diol, respectively. The epimeric compound 13-ethyl-11-methylene-18,19-dinor-5β, 17α-pregnan-20-yne-3β, 17β-diol was obtained by chemical reduction of the 3-oxo compound. Mycobacterium smegmatis converted KDG to metabolites of the 5αH-series: 13-ethyl-17β-hydroxy-11- methylene-18,19-dinor-5α, 17α-pregnan-20-yn-3-one, 13-ethyl-11-methylene- 18,19-dinor-5α, 17α-pregnan-20-yne-3α,17β-diol and 13-ethyl-11-methylene- 18,19-dinor-5α,17α-pregnan-20-yne-3β,17β-diol. The ring A-aromatized analog of KDG 13-ethyl-11-methylene-18,19-dinor-17α-pregna-1,3,5,(10)- trien-20-yne-3,17β-diol was obtained by microbial 1-dehydrogenation with Rhodococcus rhodochrous. Additionally, chemical syntheses of the microbially obtained KDG metabolites listed above were carried out. These included Birch reduction, reduction of KDG with sodium borohydride in aqueous pyridine and in the methanol, reduction of KDG with potassium selectride in tetrahydrofuran, and dehydrogenation of KDG with cupric-II bromide in acetonitrile. The problems encountered in chemical syntheses favor the microbial procedures. The compounds were characterized by mass spectra (MS), IR, and circular dichroism (CD). Complete assignments of 1H and 13C chemical shifts were made using homo- and heteronuclear 2-DN-NMR spectroscopy. Chromatographic [gas-liquid chromatography (GLC), high performance liquid chromatography (HPLC), thin-layer chromatography (TLC)] data of all the prepared KDG metabolites are presented.